SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:7b8552b5-4189-419a-aeb3-e2bc1d202441"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:7b8552b5-4189-419a-aeb3-e2bc1d202441" > Mouse monoclonal an...

Mouse monoclonal antibodies against outer membrane proteins of a vaccine strain of Neisseria meningitidis B : 4:P1.15

Cruz, Silian (författare)
Center for Genetic Engineering and Biotechnology (CIGB)
Musacchio, Alexis (författare)
Center for Genetic Engineering and Biotechnology (CIGB)
Fernàndez-De-Cossio, Maria E. (författare)
Center for Genetic Engineering and Biotechnology (CIGB)
visa fler...
Ohlin, Mats (författare)
Lund University,Lunds universitet,Institutionen för immunteknologi,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Immunotechnology,Departments at LTH,Faculty of Engineering, LTH
Nazábal, Consuelo (författare)
Center for Genetic Engineering and Biotechnology (CIGB)
Freyre, Freya (författare)
Center for Genetic Engineering and Biotechnology (CIGB)
Borrebaeck, C. A K (författare)
Lund University,Lunds universitet,Institutionen för immunteknologi,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Immunotechnology,Departments at LTH,Faculty of Engineering, LTH
Gavilondo, Jorge V. (författare)
visa färre...
 (creator_code:org_t)
1998
1998
Engelska 6 s.
Ingår i: Minerva Biotecnologica. - 1120-4826. ; 10:2, s. 65-70
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background. Neisseria meningitidis (Nm) is a Gram negative diplococcus causing bacterial meningitis and fulminant septicemia. In order to allow efficient characterization of infecting strains, antibody reagents for use as analytical tools have proven to be invaluable tools. Similarly, antibodies against relevant bacterial antigens may guide in the selection of components to be included in developing vaccine strategies. Methods. We have thus developed mouse monoclonal antibodies specific for class 1, 3 and 5 antigens expressed by the B:4:P1.15 isolate CU385/83, also being used in a recently developed protective vaccine. In particular, two antibodies CB-Nm.1 and CB- Nm.2 recognize epitopes partly overlapping the subserotype (class 1 antigens) and serotype (class 3 antigen) specificities detected by the previously defined antibodies C6 and 15-1-P4 respectively, were evaluated. Results. As judged by strain recognition, the absolute requirement for binding differs between both the class 1-specific and class 3 specific antibodies suggesting the importance of using multiple antibodies when evaluating subserotype/serotype characteristics of clinical isolates of Nm by serological methods. Conclusion. Furthermore, the development of antibodies crossreactive with subserotype/serotype antigens may partly explain the ability of outer membrane protein vaccine to induce protective activity against strains considered as carrying different class 1 and 3 antigens as determined by available (sub)serotyping reagents.

Nyckelord

Antibodies, monoclonal
Bacterial outer membrane proteins
Neisseria meningitidis

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy